STAT
STAT+: Pharmalittle: We’re reading about a Lilly gene therapy for cholesterol, three new Lilly deals, and more
Eli Lilly reported that a high dose of its gene-editing therapy reduced cholesterol levels by 62% in participants in a…
health · source
STAT News on WeSearch
Recent health headlines from STAT News.
STAT News
STAT+: Eli Lilly to buy three small vaccine developers
Eli Lilly is acquiring three small vaccine developers, expanding its work in infectious diseases and giving the field…
STAT News
STAT+: How Kyle Diamantas defied expectations as he rose to lead the FDA
WASHINGTON — People in the food world didn’t know what to expect when the Trump administration appointed a…
STAT News
Opinion: The Ebola outbreak will lead to devastating violence against women and girls
“Women and girls in eastern Congo will be harmed in predictable, named ways over the next 12 months,” write…
STAT News
Opinion: 8 former CDC directors: Reform PEPFAR, don’t dismantle it
A State Department plan scheduled to be implemented June 1 would strip the U.S. of decades of disease defense, write…
STAT News
STAT+: An AI biotech CEO sets the record straight on AI drug development hype
CEO of BigHat Biosciences, which designs antibody therapies using machine-learning, on how AI can, and cannot, help in…
STAT News
Opinion: The innovation trap: How pharma weaponizes a word to extend monopolies
“Just because a company invests does not mean it has invented anything novel,” Tahir Amin and Rohit Malpani write in…
STAT
STAT+: Eli Lilly says Verve’s gene editor lowers cholesterol levels in early study
Eli Lilly said Monday that a high dose of its gene-editing therapy reduced cholesterol levels by 62% in participants…
STAT News
Opinion: How the perimenopause movement is hurting women
The perimenopause movement is criticized for portraying women as victims of their hormones, according to experts…
STAT News
STAT+: Congress slashed Medicaid funding to providers. The Trump administration wants to cut even further
Hospitals and other providers are bracing for an end to the extra money they’ve gotten for treating Medicaid patients,…
STAT
A CDC page on mpox caught in political crosshairs
Seed oil panic, how STIs spread, and more health news from Morning Rounds
STAT
STAT+: Pharmalittle: We’re reading about a Parkinson’s drug setback, a Merck lung cancer therapy, and more
Biogen and Denali said their experimental Parkinson’s therapy failed to slow the degenerative brain disorder in a…
STAT News
STAT+: Longevity startup Retro Biosciences says latest fundraising values it at $1.8 billion
Retro Biosciences, the longevity startup backed by OpenAI CEO Sam Altman, has raised more money at a $1.8 billion…
STAT News
A federal office of men’s health has never been closer, yet it’s likely still years away
The establishment of a federal office of men's health is gaining bipartisan support but is still likely years away.…
STAT News
STAT+: Genentech is soliciting research that can be used to blunt pharma reforms in Washington
How a pharma company is soliciting research that can be used to blunt pharma proposed reforms in Washington.
STAT News
Opinion: Check-in and intake at the doctor’s office are perfect for AI
The author argues that the check-in and intake process at medical offices could be improved with the use of AI…
STAT News
Opinion: The seed oil panic is hurting my cardiac patients
The article discusses the negative impact of the seed oil panic on cardiac patients. It argues that vegetable oils,…
STAT
Mass General Brigham says it is saving more lives. Some doctors aren’t so sure.
Mass General Brigham claims to have saved more lives through improved quality metrics and hospital integration.…
STAT
STAT+: Closely watched experimental Parkinson’s drug fails key clinical trial
Biogen and Denali Therapeutics said a closely watched experimental therapy for Parkinson’s disease failed to slow the…
STAT News
Guarding biotech from China and big bets in longevity
On this week’s episode of “The Readout LOUD,” the hosts discuss STAT's Breakthrough Summit West, where powerful…
STAT
STAT+: Immunovant shares surge on arthritis trial data
Trial results for Lilly's "triple-G" drug, FDA's leadership purge leaves chaos, and more biotech news from The Readout
STAT
STAT+: Acting head of NIH’s infectious disease institute reported to have stepped down
Jeffery Taubenberger has reportedly stepped down as the acting head of the National Institute for Allergy and…
STAT
STAT+: Elevance executive ordered to testify in Medicare Advantage fraud case
Peter Haytaian, a former executive at Elevance Health, has been ordered to testify in a Medicare Advantage fraud case.…
STAT
Live: Senate committee questions NIH director on 2027 budget
NIH Director Jay Bhattacharya is testifying before the Senate Appropriations Committee regarding the proposed budget…
STAT
STAT+: Pharmalittle: We’re reading about a Lilly obesity drug trial, statistics for an Alzheimer’s drug, and more
Eli Lilly reported that in a late-stage trial, its next-generation obesity drug led to weight loss approaching the…
STAT
STAT+: Lilly’s ‘triple-G’ drug leads to bariatric-surgery levels of weight loss in trial
A next-gen Eli Lilly obesity drug led to bariatric-surgery levels of weight loss in a study, but also saw patients…
STAT
Opinion: Living with bullet fragments in the body can have long-term medical consequences
Living with retained bullet fragments can lead to significant long-term health issues for survivors of gun violence.…
STAT
Are ‘AI co-scientist’ tools actually useful for scientists?
Recent papers from Google and FutureHouse explore the utility of AI 'co-scientist' tools in scientific research. While…
STAT
Opinion: STAT+: Dark times ahead at the FDA
It almost feels like the Trump administration is intentionally breaking the FDA, writes Lab Dish columnist Paul…
STAT
STAT+: After warning letter, Whoop and FDA in discussions about controversial blood pressure feature
Whoop is currently in discussions with the FDA regarding a blood pressure feature that the agency claims requires…
STAT News
Congressional Democrats try to force a vote to end Medicare AI prior authorization pilot
Congressional Democrats are pushing to end a Medicare pilot program that uses artificial intelligence for prior…
STAT News
Surgeon General’s office issues warning on screen time for children
The U.S. Surgeon General's office has issued a warning regarding children's screen time, urging families and schools…
STAT News
STAT+: Florida hospitals win $8 billion in extra Medicaid funds
Florida hospitals are set to receive nearly $8 billion in supplemental Medicaid funds approved by the federal…
STAT News
STAT+: Scientists track cellular disruptions that lead to type 1 diabetes
Growing evidence suggests it takes a sustained viral infection in the right genetic environment to lead to type 1…
STAT
Opinion: I saw Ebola as both doctor and patient. I wish people cared more about the Africans I worked alongside
The article discusses the ongoing Ebola outbreak in the Democratic Republic of the Congo and highlights the challenges…
STAT
STAT+: Biotech execs, academic expert lament impact of FDA turnover on rare disease drug development
Executives in the biotech industry are expressing concerns over the recent turnover at the FDA, which they believe is…
STAT
STAT+: Drugmakers guard IP more tightly amid China competition
The FDA's new path, the status of animal testing, and other biotech news from The Readout
STAT
STAT+: Kennedy names interim surgeon general amid vacancies atop health department
Stephanie Haridopolos, a family medicine physician and senior HHS adviser, will take on the surgeon general's duties…
STAT
STAT+: Pharmalittle: We’re reading about biotech investors’ mood, a former FDA head’s confidence, and more
For Wall Street, the political risk of investing in drug companies has been demoted in comparison to other concerns
STAT
There’s a leadership vacuum at NIH, too
The article discusses the leadership challenges at the National Institutes of Health (NIH) amid a broader health…
STAT
After Rubio’s critique, WHO defends work on Ebola response
The WHO defended its Ebola response, noting it's national authorities who detect outbreaks. Marco Rubio had said the…
STAT
Opinion: The rise of perimenopause misinformation
Are too many symptoms blamed on perimenopause? Two experts weigh in on the “First Opinion Podcast.”
STAT
STAT+: OpenEvidence makes its pitch to hospitals. ‘We’re not crazy monsters’
OpenEvidence CTO Zachary Ziegler said, at the STAT Breakthrough Summit West, that the company is looking beyond…
STAT
NIH behind in filling top roles, with 15 of 27 institutes led by acting directors
An NIH leadership vacuum has persisted for months, with 15 of the 27 institutes being led by acting directors.
STAT
STAT+: Senate Democrats propose adding long-term care benefit to Medicare
It's part of Democrats' strategy to focus on health care affordability and access in drawing contrasts with…
STAT
STAT+: 23andMe offers to connect users’ DNA data with medical records
23andMe is partnering with HealthEx to allow users to import their medical records, the company said Tuesday at STAT…
STAT
STAT+: Marc Tessier-Lavigne addresses new book’s allegations about his conduct in Stanford misconduct case
Marc Tessier-Lavigne, former president of Stanford University, addressed allegations regarding his resignation during…
STAT News
STAT+: Virginia governor vetoes legislation to create an advisory panel to lower the cost of prescription drugs
Virginia's governor vetoed a closely watched effort to create an advisory panel to lower prescription drug costs.
STAT News
STAT+: This spine surgery usually costs $1,400. Under No Surprises Act arbitration? $34,000
A recent analysis highlights the significant disparity in costs for lumbar laminectomy surgeries under the No…
STAT News
How AI helped treat a newborn’s ultra rare disease. ‘It was almost like a light switch.’
The parents of Jorie Krause told the audience at STAT's Breakthrough Summit about how AI helped their daughter who was…
How WeSearch handles this source
WeSearch's declared handling of STAT News's content. Indexing, snippets, summaries, retrieval and training are separate questions — see the rights registry or read this source's machine-readable record.
Indexing: Allowed
Snippet: Allowed
AI summary: Limited
Retrieval / RAG: Not asserted
Model training: Not asserted
Commercial reuse: Not permitted